Xiaodan Wei

3.5k total citations · 1 hit paper
53 papers, 2.6k citations indexed

About

Xiaodan Wei is a scholar working on Biomedical Engineering, Molecular Biology and Materials Chemistry. According to data from OpenAlex, Xiaodan Wei has authored 53 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Biomedical Engineering, 10 papers in Molecular Biology and 10 papers in Materials Chemistry. Recurrent topics in Xiaodan Wei's work include Nanoplatforms for cancer theranostics (22 papers), Nanoparticle-Based Drug Delivery (6 papers) and Extracellular vesicles in disease (5 papers). Xiaodan Wei is often cited by papers focused on Nanoplatforms for cancer theranostics (22 papers), Nanoparticle-Based Drug Delivery (6 papers) and Extracellular vesicles in disease (5 papers). Xiaodan Wei collaborates with scholars based in China, United States and Sweden. Xiaodan Wei's co-authors include Hertzel C. Gerstein, Lars Køber, Rafael Díaz, Francesca Lawson, Scott D. Solomon, Eldrin F. Lewis, John J.V. McMurray, Jean‐Claude Tardif, Kenneth Dickstein and Aldo P. Maggioni and has published in prestigious journals such as New England Journal of Medicine, ACS Nano and PLoS ONE.

In The Last Decade

Xiaodan Wei

50 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome

2015 1.7k citations Xiaodan Wei et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xiaodan Wei China	20	1.7k	914	569	366	356	53	2.6k
Ping Guo United States	28	537 0.3×	944 1.0×	1.5k 2.6×	363 1.0×	78 0.2×	85	3.3k
Victor Petrov Russia	17	402 0.2×	553 0.6×	337 0.6×	136 0.4×	102 0.3×	98	2.1k
Kohei Ueda Japan	25	449 0.3×	519 0.6×	331 0.6×	125 0.3×	63 0.2×	85	1.7k
Giuseppe Pizzolanti Italy	26	466 0.3×	691 0.8×	195 0.3×	129 0.4×	61 0.2×	81	2.2k
John G. Yovos Greece	25	440 0.3×	759 0.8×	264 0.5×	105 0.3×	71 0.2×	81	2.1k
Xi Yang China	28	460 0.3×	1.9k 2.1×	202 0.4×	392 1.1×	53 0.1×	144	3.6k
Shin Watanabe Japan	33	1.7k 1.0×	1.3k 1.4×	1.7k 2.9×	151 0.4×	42 0.1×	134	4.2k
Atsushi Tanaka Japan	22	457 0.3×	503 0.6×	712 1.3×	123 0.3×	71 0.2×	119	2.3k
Rajbabu Pakala United States	29	181 0.1×	635 0.7×	1.1k 2.0×	174 0.5×	318 0.9×	102	2.8k
Maria P. Yavropoulou Greece	26	268 0.2×	965 1.1×	230 0.4×	124 0.3×	73 0.2×	149	2.4k

Countries citing papers authored by Xiaodan Wei

Since Specialization

Citations

This map shows the geographic impact of Xiaodan Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaodan Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaodan Wei more than expected).

Fields of papers citing papers by Xiaodan Wei

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaodan Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaodan Wei. The network helps show where Xiaodan Wei may publish in the future.

Co-authorship network of co-authors of Xiaodan Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaodan Wei. A scholar is included among the top collaborators of Xiaodan Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaodan Wei. Xiaodan Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Huang, Honglin, Ningxi Li, Zheng Yang, et al.. (2025). Advanced biomaterials and delivery modalities to alleviate cancer therapy-induced inflammation. Biomaterials. 324. 123419–123419.

Wei, Xiaodan, Xiangyan Chen, Yuanyuan Zhu, et al.. (2025). Nature‐Inspired Nanostructures from Multiple‐Species Biomembranes: Rational Engineering and Therapeutic Applications in Tumor‐Targeted Nanomedicine. Advanced Science. 12(33). e07952–e07952. 2 indexed citations

Huang, Honglin, Ningxi Li, Zeng Li, et al.. (2025). Smart biomimetic “nano-med-fireman” blocking inflammation and lactate metabolism crosstalk for normalized spatiotemporal photo-immunotherapy. Bioactive Materials. 51. 431–449. 2 indexed citations

Wei, Xiaodan, et al.. (2025). Biotin Receptor-Targeting Pt^IV Oxygen Carrying Prodrug Amphiphile for Alleviating Tumor Hypoxia Induced Immune Chemotherapy Suppression. ACS Nano. 19(13). 13300–13313. 4 indexed citations

Weidinger, Stephan, Andrew Blauvelt, Kim Papp, et al.. (2024). Phase 2b randomized clinical trial of amlitelimab, an anti-OX40 ligand antibody, in patients with moderate-to-severe atopic dermatitis. Journal of Allergy and Clinical Immunology. 155(4). 1264–1275. 12 indexed citations

Wei, Xiaodan, et al.. (2024). Near‐Infrared Light‐Triggered MXene Nanocomposite for Tumor‐Specific Mild Photothermal‐Enhanced Chemodynamic Therapy. Advanced Functional Materials. 34(44). 41 indexed citations

Li, Ningxi, Xiaodan Wei, Honglin Huang, et al.. (2023). Activatable biomimetic raspberry-like nanoplatform enabled robust cascade therapy via spatiotemporal regulation of tumor immunogenicity and immunosuppression. Chemical Engineering Journal. 479. 147563–147563. 2 indexed citations

Wei, Xiaodan, Ningxi Li, Qingzhi Li, et al.. (2023). Biomimetic Nano‐Immunoactivator via Ionic Metabolic Modulation for Strengthened NIR‐II Photothermal Immunotherapy. Small. 19(49). e2304370–e2304370. 25 indexed citations

Yang, Geng, Ting Song, Hanxi Zhang, et al.. (2023). Stimulus‐Detonated Biomimetic “Nanobomb” with Controlled Release of HSP90 Inhibitor to Disrupt Mitochondrial Function for Synergistic Gas and Photothermal Therapy. Advanced Healthcare Materials. 12(26). e2300945–e2300945. 22 indexed citations

10.

Wei, Xiaodan, Ningxi Li, Honglin Huang, et al.. (2023). Homologous Targeting Cascade Nanobioreactor for Autophagy Inhibition Amplified Tumor Catalytic Therapy. ACS Materials Letters. 5(2). 491–503. 12 indexed citations

11.

Wang, Jing, Hanxi Zhang, Yupeng Zheng, et al.. (2023). A tumor-specific ROS self-supply enhanced cascade-responsive prodrug activation nanosystem for amplified chemotherapy against multidrug-resistant tumors. Acta Biomaterialia. 164. 522–537. 10 indexed citations

12.

Zhang, Yihan, et al.. (2023). The incentive role of media companies’ executive compensation system in transformation and upgrading: Evidence from listed media companies in China. PLoS ONE. 18(6). e0286729–e0286729. 2 indexed citations

13.

Miao, Jiaming, Tala Shi, Xi Wang, et al.. (2023). Young adults' blood selenium and lung function in Shandong Province, China: A prospective cohort study. 1(1). 100013–100013. 11 indexed citations

14.

Yang, Geng, Mengyue Li, Ting Song, et al.. (2022). Polydopamine‐Engineered Theranostic Nanoscouts Enabling Intracellular HSP90 mRNAs Fluorescence Detection for Imaging‐Guided Chemo–Photothermal Therapy. Advanced Healthcare Materials. 11(23). e2201615–e2201615. 24 indexed citations

15.

Feng, Yi, Xiaoxue Xie, Hanxi Zhang, et al.. (2021). Multistage-responsive nanovehicle to improve tumor penetration for dual-modality imaging-guided photodynamic-immunotherapy. Biomaterials. 275. 120990–120990. 51 indexed citations

16.

Chen, Zhongyuan, Yueting Peng, Yichao Li, et al.. (2021). Aptamer-Dendrimer Functionalized Magnetic Nano-Octahedrons: Theranostic Drug/Gene Delivery Platform for Near-Infrared/Magnetic Resonance Imaging-Guided Magnetochemotherapy. ACS Nano. 15(10). 16683–16696. 56 indexed citations

17.

Wu, Chunhui, Qiuyue Liu, Honglin Huang, et al.. (2021). Tirapazamine encapsulated hyaluronic acid nanomicelles realized targeted and efficient photo-bioreductive cascading cancer therapy. Chinese Chemical Letters. 32(8). 2400–2404. 21 indexed citations

18.

Wei, Xiaodan, Yuan Zhang, Shoujun Yu, et al.. (2018). PDLIM5 identified by label-free quantitative proteomics as a potential novel biomarker of papillary thyroid carcinoma. Biochemical and Biophysical Research Communications. 499(2). 338–344. 24 indexed citations

19.

Wu, Guanghua, et al.. (2011). Genetic analysis of the promoter region of the GATA4 gene in patients with ventricular septal defects. Translational research. 159(5). 376–382. 16 indexed citations

20.

Krueger, Diane, Mary Checovich, Dessa Gemar, Xiaodan Wei, & Neil Binkley. (2006). Calcium Supplement Ingestion May Alter Lumbar Spine Bone Mineral Density Measurement. Journal of Clinical Densitometry. 9(2). 159–163. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact